Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 111, 107261
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse
- Foundation for the National Institutes of Health
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 51 references indexed in Scilit:
- Inappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic ReviewPLOS ONE, 2012
- Factors Leading to Excessive PolypharmacyClinics in Geriatric Medicine, 2012
- The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic reviewGeneral Hospital Psychiatry, 2010
- Global disparities in the epilepsy treatment gap: a systematic reviewBulletin of the World Health Organization, 2009
- Epilepsy treatment as a predeterminant of psychosocial ill healthEpilepsy & Behavior, 2009
- Antiepileptic monotherapy significantly impairs normative scores on common tests of executive functionsActa Neurologica Scandinavica, 2009
- BupropionDrugs, 2008
- Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and StrokeAmerican Journal of Epidemiology, 2006
- Unnecessary Drug Use in Frail Older People at Hospital DischargeJournal of the American Geriatrics Society, 2005
- Psychosocial Outcomes of Antiepileptic Drug DiscontinuationEpilepsia, 1992